Metformin + Pioglitazone
Find more information about this combination medication at the webpages for metformin and pioglitazone
Diabetes Mellitus, Type 2, Type 2 Diabetes Mellitus
.svg)
Advisory
- This medicine contains a combination of 2 drugs metformin and pioglitazone.
- metformin and pioglitazone are both used to treat the same disease or symptom but work in different ways in the body.
- Most doctors will advise making sure that each individual medicine is safe and effective before using a combination form.
Drug Status
Government Approvals
US(FDA), UK(BNF)
WHO Essential Medicine
NO
Known Teratogen
NO
Pharmaceutical Class
Biguanide and Peroxisome Proliferator Receptor alpha Agonist and Peroxisome Proliferator Receptor gamma Agonist
Controlled Drug Substance
NO
metformin + pioglitazone
Summary
Metformin and Pioglitazone are used to manage type 2 diabetes. This is a condition where the body does not use insulin properly, leading to high blood sugar levels. These medications help to control blood sugar levels.
Metformin works by reducing sugar production in the liver and improving the body's response to insulin, a hormone that regulates blood sugar. Pioglitazone enhances the body's sensitivity to insulin in muscle and fat tissues, allowing the body to use insulin more effectively. Together, these medications help control blood sugar levels.
Metformin is usually taken in doses ranging from 500 mg to 2000 mg, divided into several doses throughout the day. Pioglitazone is typically taken once daily, with doses ranging from 15 mg to 45 mg. Both medications are taken orally, usually with meals.
Common side effects of Metformin include stomach issues like diarrhea, nausea, and abdominal discomfort. Pioglitazone may cause weight gain and fluid retention, which can lead to swelling. Both medications can cause low blood sugar when used with insulin or other diabetes medications.
Metformin can cause a serious condition called lactic acidosis, especially in patients with kidney problems, liver disease, or excessive alcohol use. Pioglitazone can cause or worsen heart failure due to fluid retention. It's not recommended for patients with severe heart failure. Both medications should be used with caution in patients with liver disease.
Indications and Purpose
How does combination of Metformin and Pioglitazone work?
Metformin works by reducing glucose production in the liver and improving the body's sensitivity to insulin, which helps lower blood sugar levels. Pioglitazone enhances the body's response to insulin by acting on specific receptors, leading to increased glucose uptake in muscle and fat tissues. Both medications help control blood sugar levels in people with type 2 diabetes, but they do so through different mechanisms. Together, they provide a complementary approach to managing diabetes by addressing insulin resistance and glucose production.
How effective is combination of Metformin and Pioglitazone?
Clinical studies have shown that Metformin effectively lowers blood sugar levels by decreasing hepatic glucose production and improving insulin sensitivity. Pioglitazone has been proven to enhance insulin sensitivity and improve glycemic control by acting on PPAR receptors. Both medications have demonstrated efficacy in reducing HbA1c levels, a key marker of long-term blood sugar control. When used together, they provide a complementary approach to managing type 2 diabetes, addressing both insulin resistance and glucose production.
Directions for Use
What is the usual dose of combination of Metformin and Pioglitazone?
For Metformin, the usual starting dose for adults is 500 mg taken two or three times a day with meals, or 850 mg once a day. The dose can be gradually increased to a maximum of 2,550 mg per day, depending on the patient's response and tolerance. For Pioglitazone, the typical starting dose is 15 mg or 30 mg once daily, which can be increased to a maximum of 45 mg daily based on the patient's glycemic response. Both medications are adjusted based on individual needs and are often used in combination with other diabetes treatments.
How does one take combination of Metformin and Pioglitazone?
Metformin should be taken with meals to reduce gastrointestinal side effects, while Pioglitazone can be taken with or without food. Patients are advised to follow a healthy diet and exercise plan to enhance the effectiveness of both medications. Alcohol consumption should be limited, as it can affect blood sugar levels and increase the risk of lactic acidosis with Metformin. Regular monitoring of blood sugar levels is important, and any dietary changes should be discussed with a healthcare provider.
For how long is combination of Metformin and Pioglitazone taken?
Metformin and Pioglitazone are typically used as long-term treatments for managing type 2 diabetes. They are intended to be taken continuously to maintain blood sugar control, as they do not cure diabetes but help manage its symptoms. Regular monitoring by a healthcare provider is necessary to assess effectiveness and adjust dosages as needed. Both medications require ongoing use to sustain their benefits and are often part of a comprehensive diabetes management plan.
How long does it take for combination of Metformin and Pioglitazone to work?
Metformin and Pioglitazone are both used to manage type 2 diabetes, but they work at different rates. Metformin typically begins to lower blood sugar levels within a few days, but it may take up to two weeks to see the full effect. Pioglitazone, on the other hand, may take up to two weeks to start lowering blood sugar, with full effects potentially taking two to three months. Both medications require consistent use to maintain their effects, and they work best when combined with diet and exercise.
Warnings and Precautions
Are there harms and risks from taking combination of Metformin and Pioglitazone?
Common side effects of Metformin include gastrointestinal issues such as diarrhea, nausea, and stomach discomfort. Pioglitazone may cause weight gain, edema, and an increased risk of fractures in women. Both medications can lead to hypoglycemia when used with other diabetes treatments. Significant adverse effects include the risk of lactic acidosis with Metformin and heart failure with Pioglitazone. Patients should be monitored for these side effects, and any unusual symptoms should be reported to a healthcare provider.
Can I take combination of Metformin and Pioglitazone with other prescription drugs?
Metformin can interact with medications that affect kidney function, such as certain diuretics and contrast dyes, increasing the risk of lactic acidosis. Pioglitazone may interact with insulin and other antidiabetic drugs, increasing the risk of hypoglycemia. Both medications can interact with drugs that affect liver enzymes, altering their effectiveness. Patients should inform their healthcare provider of all medications they are taking to avoid potential interactions and ensure safe and effective treatment.
Can I take combination of Metformin and Pioglitazone if I am pregnant?
There is limited data on the use of Metformin and Pioglitazone during pregnancy. Metformin has been used in pregnancy to manage gestational diabetes, but its safety profile is not fully established. Pioglitazone is not recommended during pregnancy due to potential risks to the fetus. Both medications should only be used if the potential benefits justify the risks. Pregnant women should discuss their treatment options with their healthcare provider to ensure the best outcomes for both mother and child.
Can I take combination of Metformin and Pioglitazone while breastfeeding?
Limited data suggest that Metformin is present in breast milk, but the effects on the breastfed infant are not well established. Pioglitazone's presence in human milk is unknown, and its effects on milk production or the breastfed infant have not been studied. Due to the lack of comprehensive data, the benefits of breastfeeding should be weighed against the mother's need for these medications and any potential risks to the infant. Consultation with a healthcare provider is recommended to make an informed decision.
Who should avoid taking combination of Metformin and Pioglitazone?
Metformin carries a risk of lactic acidosis, especially in patients with kidney impairment or those undergoing procedures involving contrast dyes. Pioglitazone is contraindicated in patients with heart failure due to the risk of fluid retention and exacerbation of heart failure. Both medications should be used cautiously in patients with liver disease. Patients should be aware of these risks and report any symptoms such as unusual fatigue, difficulty breathing, or swelling to their healthcare provider immediately.
